In 2023, diuretic medicine sales in Canada stood lower than the forecasted values for subsequent years, emphasizing a consistent growth trend. For the years 2024 to 2028, the data reflects a steady increase in sales, expected to rise from 317.0 million to 367.1 million USD. Year-on-year variations show an approximate annual growth rate, and this trend, analyzed through a five-year Compound Annual Growth Rate (CAGR), indicates consistent market expansion.

Future trends to watch for:

Emerging health awareness and an aging population may drive increased demand for diuretic medications.
Potential market entry of generic versions could impact pricing strategies.
Regulatory changes and health policy adaptations may also influence market dynamics.